Guilbault Capital’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$715K Sell
1,145
-1,147
-50% -$672K 0.7% 36
2026
Q2
$1.21M Sell
2,292
-126
-5% -$58.2K 1.22% 22
2026
Q1
$1.16M Sell
2,418
-146
-6% -$74.8K 1.27% 20
2025
Q4
$1.44M Buy
+2,564
New +$1.46M 1.61% 20

Other funds holding MEDP

Guilbault Capital's MEDP Position: Q3 2026 in Review

Guilbault Capital reduced its Medpace (MEDP) stake by 50% in Q3 2026, selling an estimated $672K and leaving 1,145 shares worth $715K. The position accounts for 0.7% of the portfolio, ranked #36.

Guilbault Capital first reported a position in MEDP in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.44M in Q4 2025. 762 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Guilbault Capital held 1,145 shares of Medpace worth $715K as of Q3 2026.
  • Guilbault Capital sold 1,147 Medpace shares in Q3 2026, an estimated $672K.
  • Medpace made up 0.7% of Guilbault Capital's portfolio in Q3 2026, its #36 holding.
  • Guilbault Capital first reported a position in Medpace in Q4 2025 and has held it in 4 quarters since.
  • Guilbault Capital's Medpace position peaked at $1.44M in Q4 2025.
  • 762 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Guilbault Capital's 13F filing for Q3 2026, filed 28 Oct 2026.